NDC 0641-6135-01 - Prochlorperazine Edisylate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6135
- Requested NDC
- 0641-6135-01
- Package NDCs from labels
- 0641-6135-01, 0641-6135-25
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Effective date
- 2025-01-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Prochlorperazine Edisylate Injection, USP | Hikma Pharmaceuticals USA Inc. | 2025-01-29 | HUMAN PRESCRIPTION DRUG LABEL |
| PROCHLORPERAZINE EDISYLATE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6135-01 | Prochlorperazine Edisylate | 2 mL in 1 VIAL | INJECTION | 2 | 7 | |
| 0641-6135-25 | Prochlorperazine Edisylate | 25 in 1 CARTON | INJECTION | 25 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6135-01 | ML - Milliliter | 0641-6135 | c57f245a-6b8b-4af3-8c94-37178969094f | 1 | 2016-11-08 |
| 0641-6135-25 | ML - Milliliter | 0641-6135 | 64870d1d-901a-4468-98a4-a95dc6523b8e | 1 | 2016-11-08 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| PROCHLORPERAZINE EDISYLATE | ACTIVE INGREDIENT | PG20W5VQZS | PROCHLORPERAZINE EDISYLATE INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 2 | |
| PROCHLORPERAZINE | ACTIVE MOIETY | YHP6YLT61T | PROCHLORPERAZINE EDISYLATE INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 2 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | PROCHLORPERAZINE EDISYLATE INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 2 | |
| SACCHARIN SODIUM | INACTIVE INGREDIENT | SB8ZUX40TY | PROCHLORPERAZINE EDISYLATE INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 2 | |
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | INACTIVE INGREDIENT | 593YOG76RN | PROCHLORPERAZINE EDISYLATE INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 2 | |
| SODIUM TARTRATE DIHYDRATE | INACTIVE INGREDIENT | DIA7C37AOW | PROCHLORPERAZINE EDISYLATE INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | PROCHLORPERAZINE EDISYLATE INJECTION [WEST-WARD PHARMACEUTICALS CORP.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ivy-Dry Super | BENZYL ALCOHOL, CAMPHOR, MENTHOL | Ivy-Dry, Inc. | 4792a667-2378-4b3d-968d-9efb1866792f | 2017-12-27 | Warnings | LKG8494WBH |
| Homeoplex D | GLYCERINUM, PHYTOLACCA DECANDRA, TARAXACUM OFFICINALE, ARSENICUM ALBUM, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETYLSALICYLICUM ACIDUM, GLONOINUM, INSULINUM (SUIS), LITHIUM CARBONICUM, THYROIDINUM (SUIS), SALICYLICUM ACIDUM, ADRENOCORTICOTROPHIN, CORTISONE ACETICUM, EUGENOL, STEARYL ALCOHOL, XYLITOL, FOLLICULINUM, BENZOICUM ACIDUM, CHLORINUM, POTASSIUM SORBATE, SORBITOL, RESORCINUM, BENZYL ALCOHOL, LACTICUM ACIDUM, ISOPROPYL PALMITATE, BORICUM ACIDUM, ACETICUM ACIDUM, | Supplement Clinic, LLC. | cd6b48ab-3566-484d-8deb-15ef6f8e7e8f | 2017-11-01 | Warnings | LKG8494WBH |
| Sterile Water | WATER | Baxter Healthcare Corporation | ef3e79c5-3f58-4b36-a296-64b7d9a651c1 | 2017-10-17 | Warnings, Adverse reactions | 059QF0KO0R |
| Eye Wash | WATER | CVS Pharmacy | 049cee29-7ec2-4d5b-8308-f522acde43a7 | 2017-03-29 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | Baxter Healthcare Company | 210dc9ab-d6ca-4552-ac19-1be17792d290 | 2016-05-31 | Warnings, Adverse reactions | 059QF0KO0R |
| URELLE | HYOSCYAMINE SULFATE, METHENAMINE, METHYLENE BLUE, PHENYL SALICYLATE, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | Viatris Specialty LLC | 1d80a11c-6f86-403b-85d4-32ec1924dbe9 | 2015-01-13 | Warnings, Adverse reactions | 593YOG76RN |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 051f7347-5a76-4664-8fe2-e61b3dfcb0e4 | 2014-08-27 | 593YOG76RN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.